首页 > 最新文献

International Journal of Biochemistry & Cell Biology最新文献

英文 中文
Syndecan-2 positively regulates Wnt/β-catenin signaling in breast cancer cells Syndecan-2正调控乳腺癌细胞中Wnt/β-catenin信号
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-25 DOI: 10.1016/j.biocel.2025.106853
Leyli Naraghi , Alexey Koval , Vladimir L. Katanaev , S.Mahmoud A Najafi
Syndecans are a family of four-member transmembrane heparan sulfate proteoglycans that bind to various extracellular biomolecules, such as Wnt ligands, via their heparan sulfate chains, thereby controlling a variety of cellular processes. When dysregulated, syndecans can affect tumorigenesis and cancer progression by modulating key signaling pathways involved in the regulation of biological functions. Aberrant activation of Wnt/β-catenin signaling is a hallmark of many human tumors, including breast cancer. Studying the interplay between syndecans and Wnt signaling in human cancers is beneficial for identifying new therapeutic strategies, understanding tumor behavior and improving patient outcomes. Syndecan-2 is predominantly expressed by mesenchymal cells, and its overexpression in tumors of epithelial origin appears to induce aggressive behavior. Here, by measuring β-catenin cytoplasmic stabilization and transcriptional activity, we show that syndecan-2 expression significantly enhances the sensitivity of HEK293T cells and BT-20 triple-negative breast cancer cells to Wnt3a-induced activation of Wnt/β-catenin signaling. In addition, CRISPR/Cas9-mediated deletion of SDC2, the gene encoding syndecan-2, reduced β-catenin transcriptional activity in BT-20 cells in response to Wnt3a stimulation. This reduction was rescued by the re-expression of SDC2. Collectively, our results demonstrate that syndecan-2 is a positive regulator of canonical Wnt signaling. These results also suggest that syndecan-2 is a potential clinical target for inhibiting the progression of some human cancers.
Syndecans是一个四成员的跨膜硫酸肝素蛋白聚糖家族,通过其硫酸肝素链与各种细胞外生物分子(如Wnt配体)结合,从而控制多种细胞过程。当失调时,syndecans可以通过调节参与生物功能调节的关键信号通路来影响肿瘤发生和癌症进展。Wnt/β-连环蛋白信号的异常激活是包括乳腺癌在内的许多人类肿瘤的标志。研究人类癌症中syndecans和Wnt信号之间的相互作用有助于确定新的治疗策略,了解肿瘤行为和改善患者预后。Syndecan-2主要由间充质细胞表达,其在上皮源性肿瘤中的过度表达似乎会诱导侵袭性行为。本文通过测量β-catenin细胞质稳定性和转录活性,我们发现syndecan-2的表达显著增强了HEK293T细胞和BT-20三阴性乳腺癌细胞对wnt3a诱导的Wnt/β-catenin信号激活的敏感性。此外,CRISPR/ cas9介导的SDC2(编码syndecan-2的基因)的缺失,在Wnt3a刺激下降低了BT-20细胞中β-catenin的转录活性。SDC2的重新表达挽救了这种减少。总之,我们的研究结果表明syndecan-2是典型Wnt信号的正调节因子。这些结果还表明syndecan-2是抑制某些人类癌症进展的潜在临床靶点。
{"title":"Syndecan-2 positively regulates Wnt/β-catenin signaling in breast cancer cells","authors":"Leyli Naraghi ,&nbsp;Alexey Koval ,&nbsp;Vladimir L. Katanaev ,&nbsp;S.Mahmoud A Najafi","doi":"10.1016/j.biocel.2025.106853","DOIUrl":"10.1016/j.biocel.2025.106853","url":null,"abstract":"<div><div>Syndecans are a family of four-member transmembrane heparan sulfate proteoglycans that bind to various extracellular biomolecules, such as Wnt ligands, via their heparan sulfate chains, thereby controlling a variety of cellular processes. When dysregulated, syndecans can affect tumorigenesis and cancer progression by modulating key signaling pathways involved in the regulation of biological functions. Aberrant activation of Wnt/β-catenin signaling is a hallmark of many human tumors, including breast cancer. Studying the interplay between syndecans and Wnt signaling in human cancers is beneficial for identifying new therapeutic strategies, understanding tumor behavior and improving patient outcomes. Syndecan-2 is predominantly expressed by mesenchymal cells, and its overexpression in tumors of epithelial origin appears to induce aggressive behavior. Here, by measuring β-catenin cytoplasmic stabilization and transcriptional activity, we show that syndecan-2 expression significantly enhances the sensitivity of HEK293T cells and BT-20 triple-negative breast cancer cells to Wnt3a-induced activation of Wnt/β-catenin signaling. In addition, CRISPR/Cas9-mediated deletion of <em>SDC2</em>, the gene encoding syndecan-2, reduced β-catenin transcriptional activity in BT-20 cells in response to Wnt3a stimulation. This reduction was rescued by the re-expression of <em>SDC2</em>. Collectively, our results demonstrate that syndecan-2 is a positive regulator of canonical Wnt signaling. These results also suggest that syndecan-2 is a potential clinical target for inhibiting the progression of some human cancers.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"188 ","pages":"Article 106853"},"PeriodicalIF":2.8,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144916779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-cancer effect of Loranthus micranthus via downregulation of inflammation, tryptophan catabolism and kynurenine synthesis 微月桂通过下调炎症、色氨酸分解代谢和犬尿氨酸合成的抗癌作用
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-23 DOI: 10.1016/j.biocel.2025.106852
Azubuike P. Ebokaiwe , Lingyu Li , Ting Peng , Emmanuel M. Njoya , Zongyuan Zhou , Euslar Nnenna Onu , Guolin Zhang , Wang Fei
New therapeutic approaches are essential in the fight against breast cancer, which remains one of the top causes of mortality globally. Innovative and efficient methods of treating and preventing cancer has become expedient since its incidence rates are rising globally. Combining herbal extracts and chemotherapy have drawn a lot of attention in recent times as a cutting-edge cancer prevention approach. The wild parasitic plant Loranthus micranthus is extensively distributed throughout the world and is well-known for its therapeutic uses. Previous preclinical investigations indicated that the leaves and stem extracts of L. micranthus had the potential to suppress breast cancer. Investigating the anticancer effects of L. micranthus extracts through network pharmacology analysis, in vitro and in vivo experiments is the goal of the current study. Network pharmacology analysis revealed 207 targets and 30 bioactive phytoconstituents of L. micranthus associated with the metabolism of breast cancer. L. micranthus controlled the metabolism of tryptophan and nitrogen in breast cancer, according to KEGG analysis and in silico models. The results of the experiment showed that L. micranthus significantly reduced the synthesis of kynurenine in interferon-γ (IFN-γ)-stimulated breast cancer cells, downregulated important proteins involved in tryptophan catabolism, and produced no cytotoxic effects in human breast cancer cells (MCF 7 and MDA-MB 231) at the administered doses. The viability of T cells co-cultured with IFN-γ-treated breast cancer cells was also markedly enhanced by L. micranthus pre-treatment. The in vivo investigation showed a similar outcome, with L. micranthus treatment suppressing the inflammatory response, IDO activity/expression, lowering kynurenine levels, blocking CTLA-4 immune checkpoint and finally increasing the CD4+ T cell population in rats with DMBA-induced breast cancer.
新的治疗方法对防治乳腺癌至关重要,乳腺癌仍然是全球死亡的主要原因之一。由于全球癌症发病率不断上升,创新和有效的治疗和预防癌症的方法已成为权宜之计。近年来,将草药提取物和化疗结合起来作为一种尖端的癌症预防方法备受关注。野生寄生植物微兰花(Loranthus microranthus)广泛分布于世界各地,以其治疗用途而闻名。先前的临床前研究表明,微兰花叶和茎提取物具有抑制乳腺癌的潜力。通过网络药理学分析、体外和体内实验来研究微牛蒡提取物的抗癌作用是当前研究的目标。网络药理学分析揭示了微兰花与乳腺癌代谢相关的207个靶点和30个生物活性成分。根据KEGG分析和计算机模型,微乳杆菌控制着乳腺癌中色氨酸和氮的代谢。实验结果表明,微乳草显著降低干扰素-γ (IFN-γ)刺激的乳腺癌细胞中犬尿氨酸的合成,下调参与色氨酸分解代谢的重要蛋白,并且在给药剂量下对人乳腺癌细胞(mcf7和MDA-MB 231)没有细胞毒性作用。与IFN-γ处理过的乳腺癌细胞共培养的T细胞活力也明显增强。体内研究显示了类似的结果,微乳草治疗抑制炎症反应,IDO活性/表达,降低犬尿氨酸水平,阻断CTLA-4免疫检查点,最终增加dba诱导的乳腺癌大鼠的CD4+ T细胞群。
{"title":"Anti-cancer effect of Loranthus micranthus via downregulation of inflammation, tryptophan catabolism and kynurenine synthesis","authors":"Azubuike P. Ebokaiwe ,&nbsp;Lingyu Li ,&nbsp;Ting Peng ,&nbsp;Emmanuel M. Njoya ,&nbsp;Zongyuan Zhou ,&nbsp;Euslar Nnenna Onu ,&nbsp;Guolin Zhang ,&nbsp;Wang Fei","doi":"10.1016/j.biocel.2025.106852","DOIUrl":"10.1016/j.biocel.2025.106852","url":null,"abstract":"<div><div>New therapeutic approaches are essential in the fight against breast cancer, which remains one of the top causes of mortality globally. Innovative and efficient methods of treating and preventing cancer has become expedient since its incidence rates are rising globally. Combining herbal extracts and chemotherapy have drawn a lot of attention in recent times as a cutting-edge cancer prevention approach. The wild parasitic plant <em>Loranthus micranthus</em> is extensively distributed throughout the world and is well-known for its therapeutic uses. Previous preclinical investigations indicated that the leaves and stem extracts of <em>L. micranthus</em> had the potential to suppress breast cancer. Investigating the anticancer effects of <em>L. micranthus</em> extracts through network pharmacology analysis, in vitro and in vivo experiments is the goal of the current study. Network pharmacology analysis revealed 207 targets and 30 bioactive phytoconstituents of <em>L. micranthus</em> associated with the metabolism of breast cancer. <em>L. micranthus</em> controlled the metabolism of tryptophan and nitrogen in breast cancer, according to KEGG analysis and in silico models. The results of the experiment showed that <em>L. micranthus</em> significantly reduced the synthesis of kynurenine in interferon-γ (IFN-γ)-stimulated breast cancer cells, downregulated important proteins involved in tryptophan catabolism, and produced no cytotoxic effects in human breast cancer cells (MCF 7 and MDA-MB 231) at the administered doses. The viability of T cells co-cultured with IFN-γ-treated breast cancer cells was also markedly enhanced by <em>L. micranthus</em> pre-treatment. The in vivo investigation showed a similar outcome, with <em>L. micranthus</em> treatment suppressing the inflammatory response, IDO activity/expression, lowering kynurenine levels, blocking CTLA-4 immune checkpoint and finally increasing the CD4<sup>+</sup> T cell population in rats with DMBA-induced breast cancer.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"188 ","pages":"Article 106852"},"PeriodicalIF":2.8,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144894777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterozygous Kctd5 knockout mice exhibit abnormal lipid metabolism 杂合子Kctd5敲除小鼠表现出异常的脂质代谢
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-20 DOI: 10.1016/j.biocel.2025.106851
Qiao Ling , Manqi Cao , Hua-an Zhang , Xinjie Li , Wenhao Wang , Zhuohua Wang , Qingrong Sun , Zhijuan Liang , Weiyi Huang , Mengxuan Wang , Xin Li , Chuwen Lin , Xuan Jiang , Ji-An Pan , Xiaoxue Peng
The KCTD gene family is conserved across species, yet the knowledge of its function is limited. Recently, increasing studies focused on KCTD5 emerged. The functions of KCTD5 and its associations with various diseases were revealed. However, the function of KCTD5 in vivo has remained elusive. We generated Kctd5+/- mice with the Kctd5 gene’s exon 2 deleted using CRISPR/Cas9 technology. Breeding experiments on Kctd5+/- mice showed that only Kctd5+/- and Kctd5+/+ mice could be born normally, while Kctd5-/- embryos died in early embryonic development. Compared to Kctd5+/+ mice, Kctd5+/- mice have a shorter lifespan and exhibit spleen enlargement, abnormal blood cell counts, and metabolic disorders, including elevated cholesterol and triglyceride levels. Genome-wide gene expression analysis revealed that KCTD5 may affect the PPAR signaling pathway and subsequent the expression of Apo family genes, thereby regulating lipid metabolism. In summary, our study identified a previously unrecognized role of KCTD5 in regulating lipid metabolism and KCTD5 deficiency-induced animal phenotype, and revealed multiple correlations between KCTD5 and various molecules in mice.
KCTD基因家族是跨物种保守的,但对其功能的了解有限。近年来,对KCTD5的研究越来越多。揭示了KCTD5的功能及其与多种疾病的关系。然而,KCTD5在体内的功能仍然是未知的。我们使用CRISPR/Cas9技术生成了Kctd5基因外显子2缺失的Kctd5+/-小鼠。Kctd5+/-小鼠的育种实验表明,只有Kctd5+/-和Kctd5+/+小鼠能够正常出生,而Kctd5-/-胚胎在胚胎发育早期死亡。与Kctd5+/+小鼠相比,Kctd5+/-小鼠寿命较短,脾脏肿大,血细胞计数异常,代谢紊乱,包括胆固醇和甘油三酯水平升高。全基因组基因表达分析显示,KCTD5可能影响PPAR信号通路,进而影响Apo家族基因的表达,从而调节脂质代谢。综上所述,我们的研究发现了KCTD5在调节脂质代谢和KCTD5缺陷诱导的动物表型中的先前未被认识到的作用,并揭示了KCTD5与小鼠各种分子之间的多重相关性。
{"title":"Heterozygous Kctd5 knockout mice exhibit abnormal lipid metabolism","authors":"Qiao Ling ,&nbsp;Manqi Cao ,&nbsp;Hua-an Zhang ,&nbsp;Xinjie Li ,&nbsp;Wenhao Wang ,&nbsp;Zhuohua Wang ,&nbsp;Qingrong Sun ,&nbsp;Zhijuan Liang ,&nbsp;Weiyi Huang ,&nbsp;Mengxuan Wang ,&nbsp;Xin Li ,&nbsp;Chuwen Lin ,&nbsp;Xuan Jiang ,&nbsp;Ji-An Pan ,&nbsp;Xiaoxue Peng","doi":"10.1016/j.biocel.2025.106851","DOIUrl":"10.1016/j.biocel.2025.106851","url":null,"abstract":"<div><div>The KCTD gene family is conserved across species, yet the knowledge of its function is limited. Recently, increasing studies focused on KCTD5 emerged. The functions of KCTD5 and its associations with various diseases were revealed. However, the function of KCTD5 <em>in vivo</em> has remained elusive. We generated <em>Kctd5</em><sup>+/-</sup> mice with the <em>Kctd5</em> gene’s exon 2 deleted using CRISPR/Cas9 technology. Breeding experiments on <em>Kctd5</em><sup>+/-</sup> mice showed that only <em>Kctd5</em><sup>+/-</sup> and <em>Kctd5</em><sup>+/+</sup> mice could be born normally, while <em>Kctd5</em><sup>-/-</sup> embryos died in early embryonic development. Compared to <em>Kctd5</em><sup>+/+</sup> mice, <em>Kctd5</em><sup>+/-</sup> mice have a shorter lifespan and exhibit spleen enlargement, abnormal blood cell counts, and metabolic disorders, including elevated cholesterol and triglyceride levels. Genome-wide gene expression analysis revealed that KCTD5 may affect the PPAR signaling pathway and subsequent the expression of Apo family genes, thereby regulating lipid metabolism. In summary, our study identified a previously unrecognized role of KCTD5 in regulating lipid metabolism and KCTD5 deficiency-induced animal phenotype, and revealed multiple correlations between KCTD5 and various molecules in mice.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"188 ","pages":"Article 106851"},"PeriodicalIF":2.8,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144892029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antigen-presenting cells orchestrate mixed inflammatory endotypes in atopic dermatitis 抗原呈递细胞在特应性皮炎中协调混合炎症内型。
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-15 DOI: 10.1016/j.biocel.2025.106850
Shan Wang , Jiahao Huang , Fangping He , Jiaxiao Lin, Xinyu Zheng, Na Zhang, Ailin Tao
Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by a complex pathogenesis involving aberrant activation of multiple immune responses. In recent years, targeted biologics have demonstrated significant efficacy in treating moderate to severe AD due to their precise mechanisms. However, the complex inflammatory profile of AD poses challenges for single-target biologics, leading to suboptimal therapeutic responses. By investigating the upstream induction mechanisms of mixed immune endotypes of AD, our study examined the roles of three types of skin antigen-presenting cells (APCs) in inducing distinct inflammatory responses in AD pathogenesis, utilizing animal models and genetically deficient mice. Our findings revealed that epidermal Langerhans cells primarily recognize allergens, induce Th2 inflammation, and promote IgE production. Nlrp3 contributes to macrophage activation by the AD lesion microbiota, driving Th17 inflammation and IgG1 production. The STING pathway facilitates dendritic cell activation, exacerbates the overall inflammatory process across mixed immune endotypes of AD, and the production of IgG2a and IgG1. In summary, our study conducted a comprehensive analysis of the upstream key antigen-presenting cells and their regulatory pathways that contribute to the progression of AD-associated immune endotypes. This research provides valuable insights into upstream mechanisms for controlling AD mixed inflammatory processes and offers strategic directions for developing combination therapies targeting multiple inflammatory pathways.
特应性皮炎(AD)是一种慢性炎症性皮肤病,其发病机制复杂,涉及多种免疫反应的异常激活。近年来,靶向生物制剂由于其精确的作用机制,在治疗中重度AD方面显示出显著的疗效。然而,阿尔茨海默病复杂的炎症特征给单靶点生物制剂带来了挑战,导致治疗反应不理想。通过研究AD混合免疫内型的上游诱导机制,我们利用动物模型和基因缺陷小鼠,研究了三种类型的皮肤抗原呈递细胞(APCs)在AD发病机制中诱导不同炎症反应的作用。我们的研究结果表明,表皮朗格汉斯细胞主要识别过敏原,诱导Th2炎症,促进IgE的产生。Nlrp3有助于AD病变微生物群激活巨噬细胞,驱动Th17炎症和IgG1的产生。STING通路促进了树突状细胞的激活,加剧了AD混合免疫内型的整体炎症过程,并促进了IgG2a和IgG1的产生。综上所述,我们的研究全面分析了上游关键抗原呈递细胞及其调控途径,这些途径有助于ad相关免疫内型的进展。本研究为控制AD混合炎症过程的上游机制提供了有价值的见解,并为开发针对多种炎症途径的联合治疗提供了战略方向。
{"title":"Antigen-presenting cells orchestrate mixed inflammatory endotypes in atopic dermatitis","authors":"Shan Wang ,&nbsp;Jiahao Huang ,&nbsp;Fangping He ,&nbsp;Jiaxiao Lin,&nbsp;Xinyu Zheng,&nbsp;Na Zhang,&nbsp;Ailin Tao","doi":"10.1016/j.biocel.2025.106850","DOIUrl":"10.1016/j.biocel.2025.106850","url":null,"abstract":"<div><div>Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by a complex pathogenesis involving aberrant activation of multiple immune responses. In recent years, targeted biologics have demonstrated significant efficacy in treating moderate to severe AD due to their precise mechanisms. However, the complex inflammatory profile of AD poses challenges for single-target biologics, leading to suboptimal therapeutic responses. By investigating the upstream induction mechanisms of mixed immune endotypes of AD, our study examined the roles of three types of skin antigen-presenting cells (APCs) in inducing distinct inflammatory responses in AD pathogenesis, utilizing animal models and genetically deficient mice. Our findings revealed that epidermal Langerhans cells primarily recognize allergens, induce Th2 inflammation, and promote IgE production. Nlrp3 contributes to macrophage activation by the AD lesion microbiota, driving Th17 inflammation and IgG1 production. The STING pathway facilitates dendritic cell activation, exacerbates the overall inflammatory process across mixed immune endotypes of AD, and the production of IgG2a and IgG1. In summary, our study conducted a comprehensive analysis of the upstream key antigen-presenting cells and their regulatory pathways that contribute to the progression of AD-associated immune endotypes. This research provides valuable insights into upstream mechanisms for controlling AD mixed inflammatory processes and offers strategic directions for developing combination therapies targeting multiple inflammatory pathways.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"188 ","pages":"Article 106850"},"PeriodicalIF":2.8,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144876574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nuclear-localized SIRT1 inhibits apoptosis via deacetylating p53 核定位SIRT1通过去乙酰化p53抑制细胞凋亡。
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-08-05 DOI: 10.1016/j.biocel.2025.106841
Lin Cheng , Ge Wu , Wei Yao , Kangrong Deng , Chunsun Zhang , Tongsheng Chen
The function of silencing information regulator 1 (SIRT1) in promoting or inhibiting apoptosis remains a subject of debate. Here, we aim to evaluate the roles of nuclear-localized SIRT1 in STS/DOX-induced apoptosis. Silencing nuclear-localized SIRT1 significantly enhanced STS/DOX-induced apoptosis, while overexpression of nuclear-localized SIRT1 markedly inhibited STS/DOX-induced process, demonstrating the anti-apoptotic ability of the nuclear-localized SIRT1. Critically, silencing p53 compromised the anti-apoptotic function of nuclear-localized SIRT1, thereby underscoring the essential role of p53 in mediating SIRT1's anti-apoptotic capability. Western blot analysis further revealed that wild-type SIRT1 robustly downregulated Ac-p53 expression to inhibit apoptosis, whereas a deacetylase-defective mutant of SIRT1 (SIRT1H363Y) markedly upregulated Ac-p53 to promote apoptosis. Fluorescence resonance energy transfer (FRET) analyses for the cells co-expressing nuclear-localized SIRT1-CFP and p53-YFP showed that STS enhanced the direct interaction between SIRT1 and p53 in nucleus, suggesting that the nuclear-localized SIRT1 directly interacts with p53 to deacetylate p53, thus inhibiting apoptosis. On the contrary,overexpression of cytoplasm-localized SIRT1 markedly promoted STS/DOX-induced apoptosis, firmly demonstrating the pro-apoptotic ability of the cytoplasm-localized SIRT1. These results firmly demonstrate a notion that nuclear-localized SIRT1 inhibits apoptosis via deacetylating p53.
沉默信息调控因子1 (SIRT1)在促进或抑制细胞凋亡中的作用仍然是一个有争议的话题。在这里,我们的目的是评估核定位SIRT1在STS/ dox诱导的细胞凋亡中的作用。沉默核定位SIRT1可显著增强STS/ dox诱导的细胞凋亡,而过表达核定位SIRT1可显著抑制STS/ dox诱导的细胞凋亡过程,表明核定位SIRT1具有抗凋亡能力。关键的是,沉默p53损害了核定位SIRT1的抗凋亡功能,从而强调了p53在介导SIRT1抗凋亡能力中的重要作用。Western blot分析进一步发现,野生型SIRT1显著下调Ac-p53表达抑制细胞凋亡,而SIRT1脱乙酰酶缺陷突变体(SIRT1H363Y)显著上调Ac-p53表达促进细胞凋亡。对核定位SIRT1- cfp和p53- yfp共表达细胞的荧光共振能量转移(FRET)分析显示,STS增强了SIRT1与细胞核内p53的直接相互作用,提示核定位SIRT1直接与p53相互作用,使p53去乙酰化,从而抑制细胞凋亡。相反,胞质定位的SIRT1过表达可显著促进STS/ dox诱导的细胞凋亡,充分证明胞质定位的SIRT1具有促凋亡能力。这些结果坚定地证明了核定位SIRT1通过去乙酰化p53抑制细胞凋亡的观点。
{"title":"Nuclear-localized SIRT1 inhibits apoptosis via deacetylating p53","authors":"Lin Cheng ,&nbsp;Ge Wu ,&nbsp;Wei Yao ,&nbsp;Kangrong Deng ,&nbsp;Chunsun Zhang ,&nbsp;Tongsheng Chen","doi":"10.1016/j.biocel.2025.106841","DOIUrl":"10.1016/j.biocel.2025.106841","url":null,"abstract":"<div><div>The function of silencing information regulator 1 (SIRT1) in promoting or inhibiting apoptosis remains a subject of debate. Here, we aim to evaluate the roles of nuclear-localized SIRT1 in STS/DOX-induced apoptosis. Silencing nuclear-localized SIRT1 significantly enhanced STS/DOX-induced apoptosis, while overexpression of nuclear-localized SIRT1 markedly inhibited STS/DOX-induced process, demonstrating the anti-apoptotic ability of the nuclear-localized SIRT1. Critically, silencing p53 compromised the anti-apoptotic function of nuclear-localized SIRT1, thereby underscoring the essential role of p53 in mediating SIRT1's anti-apoptotic capability. Western blot analysis further revealed that wild-type SIRT1 robustly downregulated Ac-p53 expression to inhibit apoptosis, whereas a deacetylase-defective mutant of SIRT1 (SIRT1<sup>H363Y</sup>) markedly upregulated Ac-p53 to promote apoptosis. Fluorescence resonance energy transfer (FRET) analyses for the cells co-expressing nuclear-localized SIRT1-CFP and p53-YFP showed that STS enhanced the direct interaction between SIRT1 and p53 in nucleus, suggesting that the nuclear-localized SIRT1 directly interacts with p53 to deacetylate p53, thus inhibiting apoptosis. On the contrary,overexpression of cytoplasm-localized SIRT1 markedly promoted STS/DOX-induced apoptosis, firmly demonstrating the pro-apoptotic ability of the cytoplasm-localized SIRT1. These results firmly demonstrate a notion that nuclear-localized SIRT1 inhibits apoptosis via deacetylating p53.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"187 ","pages":"Article 106841"},"PeriodicalIF":2.8,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substrate stiffness modulates osteogenic differentiation of BMMSCs via the hedgehog signaling pathway 底物硬度通过Hedgehog信号通路调节BMMSCs的成骨分化。
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-07-23 DOI: 10.1016/j.biocel.2025.106840
Chengyang Sun , Mengying Jin , Ying Lian , Aodi Jiang , Hongfeng Zhai
Substrate stiffness is a critical biophysical cue regulating mesenchymal stem cell (MSC) fate, yet the underlying mechanisms remain incompletely understood. Here, we investigated how substrate stiffness modulates the osteogenic differentiation of bone marrow mesenchymal stem cells (BMMSCs) and the involvement of the Hedgehog (Hh) signaling pathway in this process. Polydimethylsiloxane (PDMS) substrates with tunable stiffness (soft: 32.73 ± 3.74 kPa; medium: 57.59 ± 5.65 kPa; stiff: 147.4 ± 11.04 kPa) were fabricated and functionalized with arginine-glycine-aspartic acid (RGD) peptides to mimic the mechanical microenvironment of bone tissue. BMMSCs cultured on stiff substrates exhibited enhanced cell spreading and proliferation compared to those on soft substrates. Osteogenic induction experiments revealed that stiff substrates significantly upregulated alkaline phosphatase (ALP) expression and calcium nodule formation after 7 and 21 days, respectively. Mechanistically, the Hh pathway was activated on stiff substrates at day 3. Inhibition of Hh signaling using GANT61 impeded stiffness-induced effects, reducing cell spreading, proliferation, and osteogenic differentiation. These findings demonstrate that substrate stiffness promotes BMMSCs osteogenesis in a Hh signaling-dependent manner, providing new insights into the mechanobiology of bone regeneration and informing the design of stiffness-optimized biomaterials for tissue engineering applications.
基质硬度是调节间充质干细胞(MSC)命运的关键生物物理线索,但其潜在机制尚不完全清楚。在这里,我们研究了底物硬度如何调节骨髓间充质干细胞(BMMSCs)的成骨分化以及Hedgehog (Hh)信号通路在这一过程中的参与。硬度可调的聚二甲基硅氧烷(PDMS)衬底(软:32.73±3.74 kPa;介质:57.59±5.65 kPa;采用精氨酸-甘氨酸-天冬氨酸(RGD)多肽对其进行功能化,模拟骨组织的机械微环境。与在软基质上培养的骨髓间充质干细胞相比,在硬基质上培养的骨髓间充质干细胞表现出更强的细胞扩散和增殖。成骨诱导实验显示,在7天和21天后,硬底物分别显著上调碱性磷酸酶(ALP)的表达和钙结节的形成。机械上,Hh通路在第3天在坚硬底物上被激活。使用GANT61抑制Hh信号会阻碍僵硬诱导的效应,减少细胞扩散、增殖和成骨分化。这些发现表明,基质刚度以Hh信号依赖的方式促进BMMSCs成骨,为骨再生的机械生物学提供了新的见解,并为组织工程应用中刚度优化的生物材料的设计提供了信息。
{"title":"Substrate stiffness modulates osteogenic differentiation of BMMSCs via the hedgehog signaling pathway","authors":"Chengyang Sun ,&nbsp;Mengying Jin ,&nbsp;Ying Lian ,&nbsp;Aodi Jiang ,&nbsp;Hongfeng Zhai","doi":"10.1016/j.biocel.2025.106840","DOIUrl":"10.1016/j.biocel.2025.106840","url":null,"abstract":"<div><div>Substrate stiffness is a critical biophysical cue regulating mesenchymal stem cell (MSC) fate, yet the underlying mechanisms remain incompletely understood. Here, we investigated how substrate stiffness modulates the osteogenic differentiation of bone marrow mesenchymal stem cells (BMMSCs) and the involvement of the Hedgehog (Hh) signaling pathway in this process. Polydimethylsiloxane (PDMS) substrates with tunable stiffness (soft: 32.73 ± 3.74 kPa; medium: 57.59 ± 5.65 kPa; stiff: 147.4 ± 11.04 kPa) were fabricated and functionalized with arginine-glycine-aspartic acid (RGD) peptides to mimic the mechanical microenvironment of bone tissue. BMMSCs cultured on stiff substrates exhibited enhanced cell spreading and proliferation compared to those on soft substrates. Osteogenic induction experiments revealed that stiff substrates significantly upregulated alkaline phosphatase (ALP) expression and calcium nodule formation after 7 and 21 days, respectively. Mechanistically, the Hh pathway was activated on stiff substrates at day 3. Inhibition of Hh signaling using GANT61 impeded stiffness-induced effects, reducing cell spreading, proliferation, and osteogenic differentiation. These findings demonstrate that substrate stiffness promotes BMMSCs osteogenesis in a Hh signaling-dependent manner, providing new insights into the mechanobiology of bone regeneration and informing the design of stiffness-optimized biomaterials for tissue engineering applications.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"187 ","pages":"Article 106840"},"PeriodicalIF":2.8,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of ERO1A by TCF21 curbs aerobic glycolysis and enhances immune recognition in lung adenocarcinoma TCF21抑制ERO1A抑制肺腺癌的有氧糖酵解并增强免疫识别。
IF 2.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-07-12 DOI: 10.1016/j.biocel.2025.106831
Xiaoyu Zheng, Bin Jiang, Yingchun Zhang, Shigao Ye, Yongchun Liu

Background

Among the many malignancies, lung adenocarcinoma (LUAD) is a top global health and life risk. The focus of this research is to explore how the TCF21/ERO1A pathway influences the immune escape mechanisms triggered by aerobic glycolysis in LUAD.

Methods

After downloading mRNA expression data from TCGA-LUAD and conducting differential expression analysis, we identified our target mRNA based on literature review. We used the hTFtarget database to forecast the upstream transcription factor (TF) of the target mRNA, and their binding relationship was verified through dual-luciferase experiments. Gene set enrichment analysis (GSEA) was performed on the target gene to probe its impact on LUAD-associated signaling pathways. qRT-PCR was used to detect the expression of ERO1A, TCF21, and PD-L1 mRNA. Western blot was employed to measure the expression levels of glycolysis-related proteins (SLC2A1, HK2, LDHA) and PD-L1 protein. Extracellular acidification rate and oxygen consumption rate were evaluated using a Seahorse metabolic analyzer. The apoptosis of CD8+ T cells and the activation status of CD8+ T cells were detected by flow cytometry. We also conducted 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay to assess the cytotoxicity of natural killer cells against LUAD cells.

Results

High expression levels of ERO1A were observed in LUAD tissues and cells. GSEA identified a notable association of ERO1A with glycolytic processes and tumor immune evasion pathways. The depletion of ERO1A deeply impaired the glycolytic capacity, immune evasion abilities, and PD-L1 expression in LUAD cells, as validated by both cellular and molecular experiments. ERO1A induced immune evasion in LUAD cells via the upregulation of PD-L1. TCF21, an upstream regulator of ERO1A, was found to be downregulated in LUAD. Dual-luciferase assays also provided evidence for the specific binding of ERO1A to TCF21. Recovery experiments showed TCF21 curbed the stimulatory effect of glycolysis on the immune evasion of LUAD cells by suppressing ERO1A expression.

Conclusion

TCF21 directs its action towards ERO1A, thereby inhibiting the glycolysis-mediated promotion of immune evasion in LUAD cells. As such, the TCF21/ERO1A axis could be harnessed as a therapeutic target and a prognosis marker in LUAD.
背景:在众多恶性肿瘤中,肺腺癌(LUAD)是全球最大的健康和生命风险。本研究的重点是探讨TCF21/ERO1A途径如何影响LUAD中有氧糖酵解引发的免疫逃逸机制。方法:从TCGA-LUAD下载mRNA表达数据并进行差异表达分析后,通过文献查阅确定目标mRNA。我们利用hTFtarget数据库预测目标mRNA的上游转录因子(TF),并通过双荧光素酶实验验证它们的结合关系。对靶基因进行基因集富集分析(GSEA),探讨其对luad相关信号通路的影响。采用qRT-PCR检测ERO1A、TCF21、PD-L1 mRNA的表达。Western blot检测糖酵解相关蛋白(SLC2A1、HK2、LDHA)和PD-L1蛋白的表达水平。使用海马代谢分析仪评估细胞外酸化速率和耗氧量。流式细胞术检测CD8+ T细胞凋亡及活化状态。我们还进行了3-(4,5-二甲基噻唑-2-基)-2,5-二苯四唑(MTT)测定,以评估自然杀伤细胞对LUAD细胞的细胞毒性。结果:ERO1A在LUAD组织和细胞中高表达。GSEA发现了ERO1A与糖酵解过程和肿瘤免疫逃避途径的显著关联。经细胞和分子实验证实,ERO1A的缺失严重损害了LUAD细胞的糖酵解能力、免疫逃避能力和PD-L1表达。ERO1A通过上调PD-L1诱导LUAD细胞的免疫逃避。TCF21是ERO1A的上游调控因子,在LUAD中被发现下调。双荧光素酶测定也提供了ERO1A与TCF21特异性结合的证据。恢复实验表明,TCF21通过抑制ERO1A表达抑制糖酵解对LUAD细胞免疫逃避的刺激作用。结论:TCF21直接作用于ERO1A,从而抑制糖酵解介导的LUAD细胞免疫逃避。因此,TCF21/ERO1A轴可以作为LUAD的治疗靶点和预后标志物。
{"title":"Inhibition of ERO1A by TCF21 curbs aerobic glycolysis and enhances immune recognition in lung adenocarcinoma","authors":"Xiaoyu Zheng,&nbsp;Bin Jiang,&nbsp;Yingchun Zhang,&nbsp;Shigao Ye,&nbsp;Yongchun Liu","doi":"10.1016/j.biocel.2025.106831","DOIUrl":"10.1016/j.biocel.2025.106831","url":null,"abstract":"<div><h3>Background</h3><div>Among the many malignancies, lung adenocarcinoma (LUAD) is a top global health and life risk. The focus of this research is to explore how the TCF21/ERO1A pathway influences the immune escape mechanisms triggered by aerobic glycolysis in LUAD.</div></div><div><h3>Methods</h3><div>After downloading mRNA expression data from TCGA-LUAD and conducting differential expression analysis, we identified our target mRNA based on literature review. We used the hTFtarget database to forecast the upstream transcription factor (TF) of the target mRNA, and their binding relationship was verified through dual-luciferase experiments. Gene set enrichment analysis (GSEA) was performed on the target gene to probe its impact on LUAD-associated signaling pathways. qRT-PCR was used to detect the expression of ERO1A, TCF21, and PD-L1 mRNA. Western blot was employed to measure the expression levels of glycolysis-related proteins (SLC2A1, HK2, LDHA) and PD-L1 protein. Extracellular acidification rate and oxygen consumption rate were evaluated using a Seahorse metabolic analyzer. The apoptosis of CD8<sup>+</sup> T cells and the activation status of CD8<sup>+</sup> T cells were detected by flow cytometry. We also conducted 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay to assess the cytotoxicity of natural killer cells against LUAD cells.</div></div><div><h3>Results</h3><div>High expression levels of ERO1A were observed in LUAD tissues and cells. GSEA identified a notable association of ERO1A with glycolytic processes and tumor immune evasion pathways. The depletion of ERO1A deeply impaired the glycolytic capacity, immune evasion abilities, and PD-L1 expression in LUAD cells, as validated by both cellular and molecular experiments. ERO1A induced immune evasion in LUAD cells via the upregulation of PD-L1. TCF21, an upstream regulator of ERO1A, was found to be downregulated in LUAD. Dual-luciferase assays also provided evidence for the specific binding of ERO1A to TCF21. Recovery experiments showed TCF21 curbed the stimulatory effect of glycolysis on the immune evasion of LUAD cells by suppressing ERO1A expression.</div></div><div><h3>Conclusion</h3><div>TCF21 directs its action towards ERO1A, thereby inhibiting the glycolysis-mediated promotion of immune evasion in LUAD cells. As such, the TCF21/ERO1A axis could be harnessed as a therapeutic target and a prognosis marker in LUAD.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"187 ","pages":"Article 106831"},"PeriodicalIF":2.8,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144638591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction notice to “Towards tailored exosomes: The exosomal tetraspanin web contributes to target cell selection” [Intern. J. Biochem. Cell Biol., 44/9 (2012) 1574–1584] 对“定制外泌体:外泌体四蛋白网有助于靶细胞选择”的撤回通知[实习生]。学生物化学j。细胞生物。科学通报,44/9(2012):1574-1584。
IF 3.4 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-07-10 DOI: 10.1016/j.biocel.2025.106824
Sanyukta Rana , Shijing Yue , Daniela Stadel , Margot Zöller
{"title":"Retraction notice to “Towards tailored exosomes: The exosomal tetraspanin web contributes to target cell selection” [Intern. J. Biochem. Cell Biol., 44/9 (2012) 1574–1584]","authors":"Sanyukta Rana ,&nbsp;Shijing Yue ,&nbsp;Daniela Stadel ,&nbsp;Margot Zöller","doi":"10.1016/j.biocel.2025.106824","DOIUrl":"10.1016/j.biocel.2025.106824","url":null,"abstract":"","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"186 ","pages":"Article 106824"},"PeriodicalIF":3.4,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144621048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Inhibition of M2 macrophage-mediated mesenchymal stem cell migration: Boldine attenuates elbow heterotopic ossification” [Int. J. Biochem. Cell Biol. 185 (2025) 106787] 对“抑制M2巨噬细胞介导的间充质干细胞迁移:Boldine减轻肘关节异位骨化”的更正[j]。学生物化学j。中国生物医学工程学报,2015(5):387 - 387。
IF 3.4 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.biocel.2025.106829
Fengteng Shen , Yansong Chen , Zhikun Xu , Wei Wang , Guofang Chen , Fusheng Ye
{"title":"Corrigendum to “Inhibition of M2 macrophage-mediated mesenchymal stem cell migration: Boldine attenuates elbow heterotopic ossification” [Int. J. Biochem. Cell Biol. 185 (2025) 106787]","authors":"Fengteng Shen ,&nbsp;Yansong Chen ,&nbsp;Zhikun Xu ,&nbsp;Wei Wang ,&nbsp;Guofang Chen ,&nbsp;Fusheng Ye","doi":"10.1016/j.biocel.2025.106829","DOIUrl":"10.1016/j.biocel.2025.106829","url":null,"abstract":"","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"186 ","pages":"Article 106829"},"PeriodicalIF":3.4,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Purinosomes and lysosomes interact to maintain the purine pools 嘌呤酶体和溶酶体相互作用维持嘌呤池。
IF 3.4 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-07-05 DOI: 10.1016/j.biocel.2025.106830
Yubing Liu , Vidhi Pareek , Dipankar Bhowmik , Xin Zhang , Stephen J. Benkovic
Purines are the building blocks of DNA/RNA and hence essential metabolites. While the contributions of external purine salvage as well as the de novo purine biosynthesis (DNPB) have been widely studied, the contribution of lysosome mediated DNA/RNA digestion and external reabsorption into the cytosol remains unknown. Here, we address that question as well as the role of lysosome-mediated purine recycling and its coordination with DNPB in maintaining total purine pools in human cancer cell lines. By combining in-cell stable isotope incorporation assay with quantitative metabolomics we show: cellular uptake of external purines and their internal generation are equivalent; an upregulation in lysosome biogenesis that functions in response to purine deficiency caused by methotrexate (MTX) and lometrexol (LTX) treatment. This leads to increased RNA digestion as visualized by a newly developed intracellular RNA-FRET oligo assay. Interestingly, downregulation of lysosomal RNase activity through knockdown of RNAseT2 increased RNA accumulation and a compensating increase in DNPB.
嘌呤是DNA/RNA的组成部分,因此是必需的代谢物。虽然外界嘌呤回收和从头嘌呤生物合成(DNPB)的作用已经得到了广泛的研究,但溶酶体介导的DNA/RNA消化和外部再吸收到细胞质中的作用仍然未知。在这里,我们解决了这个问题,以及溶酶体介导的嘌呤再循环及其与DNPB在维持人类癌细胞系总嘌呤库中的协调作用。通过将细胞内稳定同位素掺入测定与定量代谢组学相结合,我们发现:细胞摄取的外部嘌呤与它们的内部生成是等同的;甲氨蝶呤(MTX)和乐美曲醇(LTX)治疗引起嘌呤缺乏时溶酶体生物发生的上调。这导致增加的RNA消化,通过新开发的细胞内RNA- fret寡核苷酸测定可视化。有趣的是,通过敲低RNAseT2来下调溶酶体RNase活性增加了RNA积累和DNPB的补偿性增加。
{"title":"Purinosomes and lysosomes interact to maintain the purine pools","authors":"Yubing Liu ,&nbsp;Vidhi Pareek ,&nbsp;Dipankar Bhowmik ,&nbsp;Xin Zhang ,&nbsp;Stephen J. Benkovic","doi":"10.1016/j.biocel.2025.106830","DOIUrl":"10.1016/j.biocel.2025.106830","url":null,"abstract":"<div><div>Purines are the building blocks of DNA/RNA and hence essential metabolites. While the contributions of external purine salvage as well as the <em>de novo</em> purine biosynthesis (DNPB) have been widely studied, the contribution of lysosome mediated DNA/RNA digestion and external reabsorption into the cytosol remains unknown. Here, we address that question as well as the role of lysosome-mediated purine recycling and its coordination with DNPB in maintaining total purine pools in human cancer cell lines. By combining in-cell stable isotope incorporation assay with quantitative metabolomics we show: cellular uptake of external purines and their internal generation are equivalent; an upregulation in lysosome biogenesis that functions in response to purine deficiency caused by methotrexate (MTX) and lometrexol (LTX) treatment. This leads to increased RNA digestion as visualized by a newly developed intracellular RNA-FRET oligo assay. Interestingly, downregulation of lysosomal RNase activity through knockdown of RNAseT2 increased RNA accumulation and a compensating increase in DNPB.</div></div>","PeriodicalId":50335,"journal":{"name":"International Journal of Biochemistry & Cell Biology","volume":"186 ","pages":"Article 106830"},"PeriodicalIF":3.4,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144585527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Biochemistry & Cell Biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1